Colin Glenn Begley, Chief Scientific Officer & SVP at TETRALOGIC PHARMACEUTICALS CORP (TLOG), bought 5,900 shares at $6.16 ($36K) on 2014-12-10, disclosed to the SEC on 2014-12-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TLOG | BUY | 2014-11-28 | $7K | — | Filing → |